J
Joseph S. Bresee
Researcher at Centers for Disease Control and Prevention
Publications - 261
Citations - 35039
Joseph S. Bresee is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Rotavirus & Vaccination. The author has an hindex of 78, co-authored 255 publications receiving 32225 citations. Previous affiliations of Joseph S. Bresee include National Center for Immunization and Respiratory Diseases.
Papers
More filters
Journal Article
Rotavirus surveillance data from Kunming Children's Hospital, 1998-2001
Li-jie Zhang,Zeng-Qing Du,Qing Zhang,Hong-yu Kang,Li-shu Zheng,Xiao-mei Liu,Hua-ping Xie,Hong-yan Yang,Yan-chun Wang,Bernard Ivanoff,R I Glass,Joseph S. Bresee,X I Jiang,Paul E. Kilgore,Zhao-yin Fang +14 more
TL;DR: Rotavirus was the major cause of acute diarrhea in Kunming and an effective rotavirus vaccine for prevention and control of rotav virus diarrhea should be developed.
Journal ArticleDOI
Seasonal Influenza Morbidity Estimates Obtained From Telephone Surveys, 2007
Laurie Kamimoto,Gary L. Euler,Peng-jun Lu,Arthur Reingold,James L. Hadler,Kenneth A. Gershman,Monica M. Farley,Pauline Terebuh,Patricia Ryan,Ruth Lynfield,Bernadette A. Albanese,Ann Thomas,Allen S. Craig,William Schaffner,Lyn Finelli,Joseph S. Bresee,James A. Singleton +16 more
TL;DR: The authors' telephone interview-based estimates of influenza morbidity were consistent with those from national influenza surveillance systems, and telephone surveys may provide an alternative method by which population-based flu morbidity information can be gathered.
Journal ArticleDOI
Supporting national immunization technical advisory groups (NITAGs) in resource-constrained settings. New strategies and lessons learned from the Task Force for Global Health's Partnership for influenza vaccine introduction.
Antoinette Ba-Nguz,Adeel Shah,Joseph S. Bresee,Kathryn E. Lafond,Kathy Cavallaro,Abigail Shefer,Morgane Donadel,Jane F. Seward +7 more
TL;DR: Ongoing support from NITAG partners must be secured and creative approaches might be needed to help countries achieve the GVAP 2020 target and support development of sustainable vaccine policies and programs.
Journal ArticleDOI
New breath for rotavirus vaccines
TL;DR: New vaccines against rotavirus, the leading cause of severe childhood gastroenteritis worldwide, are on the threshold of introduction into immunization programs in affluent nations, but realizing the full potential of these vaccines will require demonstration of their efficacy and ensuring their affordability in the poorest populations.